Search clinical trials for: RGN-259
Total 2723 results
-
ReGenTree, LLCTerminatedNeurotrophic KeratopathyUnited States
-
ReGenTree, LLCCompletedDry Eye | Dry Eye SyndromesUnited States
-
ReGenTree, LLCCompletedDry Eye SyndromeUnited States
-
ReGenTree, LLCCompletedAssessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2Dry Eye SyndromeUnited States
-
ReGenTree, LLCRecruitingNeurotrophic KeratopathyUnited States
-
ReGenTree, LLCORA, Inc.CompletedDry Eye | Dry Eye Syndrome
-
ReGenTree, LLCPPDTerminatedDiabetesUnited States
-
RegeneRx Biopharmaceuticals, Inc.sigma-tau i.f.r. S.p.A.CompletedVenous Stasis UlcersItaly, Poland
-
Lenus Therapeutics, LLCTerminatedDystrophic Epidermolysis Bullosa | Junctional Epidermolysis BullosaUnited States
-
AllerganCompletedMeibomian Gland DysfunctionUnited States
-
AllerganCompletedUrinary Bladder, OveractiveFrance, United States, Netherlands
-
Alkahest, Inc.CompletedEnd-Stage Renal DiseaseUnited States
-
AllerganCompleted
-
AllerganCompletedHealthy VolunteersUnited States
-
AllerganCompletedErythema | RosaceaUnited States
-
Universidade Cidade de Sao PauloCompleted
-
AllerganCompletedPresbyopiaUnited States
-
Tel Aviv UniversityWolfson Medical CenterCompleted
-
AllerganTerminatedNeuralgia, PostherpeticUnited States, Austria, Poland, Germany
-
AllerganCompletedErythema | RosaceaUnited States
-
AllerganCompleted
-
AllerganCompletedNeuralgia, PostherpeticPoland, United States, Czech Republic, Germany
-
AllerganCompletedPresbyopiaUnited States
-
AllerganCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
AllerganCompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
AllerganCompleted
-
Nazan DegirmenciCompleted
-
National University Hospital, SingaporeAlexandra HospitalNot yet recruiting
-
Second Affiliated Hospital of Soochow UniversityShanghai Regenelead Therapies Co., Ltd.RecruitingAdvanced Parkinson's DiseaseChina
-
Mologen AGCompleted
-
AbbVieAbbVieRecruiting
-
Xinhua Hospital, Shanghai Jiao Tong University...Shanghai Vitalgen BioPharma Co., Ltd.RecruitingType II Gaucher DiseaseChina
-
PepGen IncRecruitingDuchenne Muscular DystrophyCanada
-
Neurogene Inc.RecruitingNeuronal Ceroid Lipofuscinosis CLN5United States, United Kingdom
-
AbbVieCompletedWet Macular Degeneration | Neovascular Age-related Macular Degeneration | Wet Age-related Macular DegenerationUnited States
-
Gordon Schanzlin New VisionAbbVieWithdrawn
-
REGENXBIO Inc.Active, not recruitingMucopolysaccharidosis Type II (MPS II)United States, Canada
-
Seagen Inc.TerminatedMultiple MyelomaUnited States
-
AgennixWithdrawn
-
RenovisUnknownSciatica | Radiculopathy | Herniated DiscUnited States
-
Alkermes, Inc.QPS Netherlands B.V.Completed
-
Balaji TamarappooCompleted
-
Xinnate ABRegion SkaneCompletedBlister | Epidermolysis Bullosa | Wound of Skin | Varicose Ulcer of Lower LimbSweden
-
Neurogene Inc.RecruitingRett SyndromeUnited States
-
REGENXBIO Inc.RecruitingDuchenne Muscular DystrophyUnited States
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Adenoid Cystic Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Endometrial Neoplasms | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder Carcinoma | HER2 Negative Breast Neoplasms | Hormone Receptor Positive Breast NeoplasmsUnited States, Spain, Canada, United Kingdom, Germany, Italy
-
University of AlbertaRoyal Alexandra HospitalRecruiting
-
Seagen Inc.TerminatedUterine Cervical Neoplasms | Stomach Neoplasms | Testicular Neoplasms | Carcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Endometrial Neoplasms | Gastroesophageal Junction CarcinomaUnited States, Canada, Spain, Sweden, United Kingdom
-
REGENXBIO Inc.Active, not recruitingHurler Syndrome | Hurler-Scheie Syndrome | Mucopolysaccharidosis Type I (MPS I)United States, Brazil, Israel
-
Seagen Inc.TerminatedColorectal Cancer | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma | Cutaneous Melanoma | Pleural Mesothelioma | HER2 Negative Breast NeoplasmsUnited States, Spain, France, Italy, United Kingdom